Prof. Dr. Gökhan Hotamışlıgil, Director of the Sabri Ülker Center for Metabolic Research at Harvard University, and his team visited İzmir University of Economics Medical Point Hospital to discuss potential collaboration on clinical research.
Regarding the visit, Veysi Kubba, Member of the Board of Directors and CEO of Medical Point Hospitals Group, stated, “First and foremost, we are pleased to welcome Prof. Dr. Gökhan Hotamışlıgil and his team, who have pioneered significant contributions to science. We closely follow their work and appreciate their achievements. As Medical Point Hospitals Group, we have continuously renewed and developed ourselves in the healthcare sector for more than a quarter of a century, and we take pride in offering the latest technologies to our guests. In this context, we provide hope to our patients with up-to-date research conducted at our Prof. Dr. A. Uğur Yılmaz Clinical Research Center. As is well known, cancer remains one of the leading causes of death worldwide, and its incidence is increasing. Patients receiving cancer treatment through clinical research live longer and have a higher quality of life compared to those treated with standard methods. Our Clinical Research Center continues to contribute to significant new research in various fields, including hematology, cardiology, endocrinology, and neurology. As highlighted in the presentation by our Chief Coordinator of the Clinical Research Center, Prof. Dr. Çağatay Arslan, we laid the foundations for new scientific endeavors through our discussions with the team from Harvard University.”
Prof. Dr. Gökhan Hotamışlıgil expressed his gratitude for the hospitality and the information provided by the Medical Point Hospitals Group management.
The meeting was attended by numerous figures, including the Rector of İzmir Institute of Technology, Yusuf Baran; the Rector of İzmir University of Economics, Prof. Dr. Hakan Abacıoğlu; the Dean of the Faculty of Medicine, Prof. Dr. İlgi Şemin; the Medical Director of IEU Medical Point Hospital, Prof. Dr. Levent B. Kıdak; General Manager Müslüm Yıldız, and other members of the management team.
